Open AccessCombination of immune check inhibitor and immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis: A case report
Author(s) -
Kunihiko Kobayashi,
Kyoichi Kaira,
Hidetoshi Iemura,
Shun Shinomiya,
Kosuke Hashimoto,
Yu Miura,
Ayako Shiono,
Fuyumi Nishihara,
Hiroshi Kagamu
Publication year - 2021
Publication title -
molecular and clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 7
eISSN - 2049-9469
pISSN - 2049-9450
DOI - 10.3892/mco.2021.2390
Subject(s) - medicine , pemetrexed , erlotinib , nivolumab , bevacizumab , lung cancer , epidermal growth factor receptor , t790m , oncology , progressive disease , adenocarcinoma , carboplatin , cancer , cancer research , immunotherapy , chemotherapy , cisplatin , gefitinib
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom